 | • レポートコード：MRC-IM30948 • 出版社/出版日：IMARC / 2023年3月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2022年10.1億ドルであった世界のポンペイ病治療市場規模が2028年には12億ドルに達し、予測期間中（2023年-2028年）、年平均3.0％成長すると予測しています。当調査資料では、ポンペイ病治療の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、治療別（酵素補充治療（ERT）、基質低減治療（SRT）、シャペロン前置換治療（CART）、その他）分析、投与経路別（経口、点滴、その他）分析、流通チャネル別（病院＆診療所薬局、小売薬局、オンライン薬局、その他）分析、疾患別（乳児型発症ポンペ病（IOPD）、古典的乳児型、非古典的乳児型、遅発性ポンペ病（LOPD）、その他）分析、地域別（北米、アジア、欧州、中南米、中東/アフリカ）分析、要因・制約・機会、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。なお、当市場の主要企業には、Amicus Therapeutics Inc.、Audentes Therapeutics Inc. (Astellas US Holding Inc.)、Oxyrane UK Limited、Sanofi S.A.、Spark Therapeutics Inc、etcなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のポンペイ病治療市場規模：治療別 - 酵素補充治療（ERT）の市場規模 - 基質低減治療（SRT）の市場規模 - シャペロン前置換治療（CART）の市場規模 - その他治療の市場規模 ・世界のポンペイ病治療市場規模：投与経路別 - 経口投与の市場規模 - 点滴投与の市場規模 - その他投与経路の市場規模 ・世界のポンペイ病治療市場規模：流通チャネル別 - 病院＆診療所薬局の市場規模 - 小売薬局の市場規模 - オンライン薬局の市場規模 - その他流通チャネルの市場規模 ・世界のポンペイ病治療市場規模：疾患別 - 乳児型発症ポンペ病（IOPD）の市場規模 - 古典的乳児型の市場規模 - 非古典的乳児型の市場規模 - 遅発性ポンペ病（LOPD）の市場規模 - その他疾患の市場規模 ・世界のポンペイ病治療市場規模：地域別 - 北米のポンペイ病治療市場規模 - アジアのポンペイ病治療市場規模 - 欧州のポンペイ病治療市場規模 - 中南米のポンペイ病治療市場規模 - 中東/アフリカのポンペイ病治療市場規模 ・要因・制約・機会 ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
Market Overview:
The global Pompe disease treatment market size reached US$ 1.01 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.20 Billion by 2028, exhibiting a growth rate (CAGR) of 3.0% during 2023-2028. The increasing number of clinical studies and trials, the rising popularity of ERT, and the growing number of patients suffering from Pompe disease represent some of the key factors driving the market.
Pompe disease is a genetic disorder caused by the buildup of a complex sugar known as glycogen in the cells of the body, which affects organs, tissues, and muscles. It is an autosomal recessive glycogen storage syndrome caused by the deficiency of lysosomal enzyme acid a-glucosidase (GAA). It is associated with weak muscles, enlarged liver, trouble breathing, hearing problem, lung infection, irregular heartbeat, and losing weight. It is diagnosed using various tools and tests, including electromyography, X-rays, and magnetic resonance imaging (MRI). Pompe disease can be treated using medications, enzyme replacement therapy (ERT), substrate reduction therapy (SRT), chaperone-advanced replacement therapy (CART), and injections, which aid in improving the quality of life.
Pompe Disease Treatment Market Trends:
There is a considerable rise in the prevalence of genetic abnormalities among individuals and an increase in the number of patients suffering from Pompe disease. This, coupled with the growing Pompe disease among infants and increasing concerns among parents about the health of their newborns, represents one of the key factors bolstering the growth of the market. Moreover, the growing geriatric population that is susceptible to developing these medical disorders is resulting in an increasing demand for Pompe disease treatment. In addition, the expanding number of clinical studies and trials to develop new treatments for Pompe disease is influencing the market positively. Apart from this, the rising awareness among people about ERT for curing Pompe disease is favoring the market growth. Furthermore, there is an increase in awareness about various treatments, including stem cell transplant, bone marrow transplantation, chemotherapy, and immunotherapy, on account of their numerous advantages. This, along with the awareness about the easy availability of ERT treatment alternatives like lumizyme, is creating a positive outlook for the market. Besides this, there is a rise in the adoption of health insurance policies that provide financial assistance and minimize healthcare expenditure for Pompe disease treatment. Additionally, governments and non-governmental organizations (NGOs) of numerous countries are undertaking measures to offer quality healthcare facilities that are accessible to all. This, along with significant improvements in the diagnostic technologies, is anticipated to provide a favorable outlook to the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global Pompe disease treatment market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on treatment, route of administration, distribution channel, and indication type.
Treatment Insights:
Enzyme Replacement Therapy (ERT)
Substrate Reduction Therapy (SRT)
Chaperone-Advanced Replacement Therapy (CART)
Others
The report has provided a detailed breakup and analysis of the Pompe disease treatment market based on the treatment. This includes enzyme replacement therapy (ERT), substrate reduction therapy (SRT), chaperone-advanced replacement therapy (CART), and others. According to the report, enzyme replacement therapy (ERT) represented the largest segment.
Route of Administration Insights:
Oral
Intravenous
Others
A detailed breakup and analysis of the Pompe disease treatment market based on the route of administration has also been provided in the report. This includes oral, intravenous, and others.
Distribution Channel Insights:
Hospital and Clinics Pharmacies
Retail Pharmacies
Online Pharmacies
Others
A detailed breakup and analysis of the Pompe disease treatment market based on the distribution channel has also been provided in the report. This includes hospital and clinics, retail, and online pharmacies, and others. According to the report, hospital and clinics pharmacies accounted for the largest market share.
Indication Type Insights:
Infantile-Onset Pompe Disease (IOPD)
Classic Infantile Form
Non-Classic Infantile Form
Late-Onset Pompe Disease (LOPD)
Others
A detailed breakup and analysis of the Pompe disease treatment market based on the indication type has also been provided in the report. This includes infantile-onset Pompe disease (IOPD), classic infantile form, non-classic infantile form, late-onset Pompe disease (LOPD), and others. According to the report, late-onset Pompe disease (LOPD) accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for Pompe disease treatment. Some of the factors driving the North America Pompe disease treatment market included the growing awareness about various alternative treatments, increasing number of clinical studies and trials, and well-established healthcare facilities.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global Pompe disease treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amicus Therapeutics Inc., Audentes Therapeutics Inc. (Astellas US Holding Inc.), Oxyrane UK Limited, Sanofi S.A., Spark Therapeutics Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global Pompe disease treatment market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global Pompe disease treatment market?
What are the key regional markets?
Which countries represent the most attractive Pompe disease treatment markets?
What is the breakup of the market based on the treatment?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the indication type?
What is the competitive structure of the global Pompe disease treatment market?
Who are the key players/companies in the global Pompe disease treatment market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pompe Disease Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Treatment
6.1 Enzyme Replacement Therapy (ERT)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Substrate Reduction Therapy (SRT)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Chaperone-Advanced Replacement Therapy (CART)
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Intravenous
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital & Clinics Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Indication Type
9.1 Infantile-Onset Pompe Disease (IOPD)
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Classic Infantile Form
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Non-Classic Infantile Form
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Late-Onset Pompe Disease (LOPD)
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
11.1 Overview
11.2 Drivers
11.3 Restraints
11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Amicus Therapeutics Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Audentes Therapeutics Inc. (Astellas US Holding Inc.)
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Oxyrane UK Limited
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Sanofi S.A.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Spark Therapeutics Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Figure 1: Global: Pompe Disease Treatment Market: Major Drivers and ChallengesFigure 2: Global: Pompe Disease Treatment Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Pompe Disease Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Pompe Disease Treatment Market: Breakup by Treatment (in %), 2022
Figure 5: Global: Pompe Disease Treatment Market: Breakup by Route of Administration (in %), 2022
Figure 6: Global: Pompe Disease Treatment Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Pompe Disease Treatment Market: Breakup by Indication Type (in %), 2022
Figure 8: Global: Pompe Disease Treatment Market: Breakup by Region (in %), 2022
Figure 9: Global: Pompe Disease Treatment (Enzyme Replacement Therapy (ERT)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Pompe Disease Treatment (Enzyme Replacement Therapy (ERT)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Pompe Disease Treatment (Substrate Reduction Therapy (SRT)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Pompe Disease Treatment (Substrate Reduction Therapy (SRT)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Pompe Disease Treatment (Chaperone-Advanced Replacement Therapy (CART)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Pompe Disease Treatment (Chaperone-Advanced Replacement Therapy (CART)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Pompe Disease Treatment (Other Treatments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Pompe Disease Treatment (Other Treatments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Pompe Disease Treatment (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Pompe Disease Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Pompe Disease Treatment (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Pompe Disease Treatment (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Pompe Disease Treatment (Other Rout of Administrations) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Pompe Disease Treatment (Other Rout of Administrations) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Pompe Disease Treatment (Hospital & Clinics Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Pompe Disease Treatment (Hospital & Clinics Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Pompe Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Pompe Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Pompe Disease Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Pompe Disease Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Pompe Disease Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Pompe Disease Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Pompe Disease Treatment (Infantile-Onset Pompe Disease (IOPD)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Pompe Disease Treatment (Infantile-Onset Pompe Disease (IOPD)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Pompe Disease Treatment (Classic Infantile Form) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Pompe Disease Treatment (Classic Infantile Form) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Pompe Disease Treatment (Non-Classic Infantile Form) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Pompe Disease Treatment (Non-Classic Infantile Form) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Pompe Disease Treatment (Late-Onset Pompe Disease (LOPD)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Pompe Disease Treatment (Late-Onset Pompe Disease (LOPD)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Pompe Disease Treatment (Other Indication Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Pompe Disease Treatment (Other Indication Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: North America: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: North America: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: United States: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: United States: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Canada: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Canada: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Asia-Pacific: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Asia-Pacific: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: China: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: China: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Japan: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Japan: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: India: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: India: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: South Korea: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: South Korea: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Australia: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Australia: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Indonesia: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Indonesia: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Others: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Others: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Europe: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Europe: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Germany: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Germany: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: France: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: France: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: United Kingdom: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: United Kingdom: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Italy: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Italy: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Spain: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Spain: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Russia: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Russia: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Others: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Others: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Latin America: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Latin America: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Brazil: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Brazil: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Mexico: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Mexico: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Others: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Others: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Middle East and Africa: Pompe Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Middle East and Africa: Pompe Disease Treatment Market: Breakup by Country (in %), 2022
Figure 89: Middle East and Africa: Pompe Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Global: Pompe Disease Treatment Industry: Drivers, Restraints, and Opportunities
Figure 91: Global: Pompe Disease Treatment Industry: Value Chain Analysis
Figure 92: Global: Pompe Disease Treatment Industry: Porter's Five Forces Analysis